Presentation is loading. Please wait.

Presentation is loading. Please wait.

Tissue Engineering of Autologous Human Heart Valves Using Cryopreserved Vascular Umbilical Cord Cells  Ralf Sodian, MD, Cora Lueders, PhD, Liv Kraemer,

Published byΠτολεμαῖος Δουμπιώτης Modified over 5 years ago

Similar presentations

Presentation on theme: "Tissue Engineering of Autologous Human Heart Valves Using Cryopreserved Vascular Umbilical Cord Cells  Ralf Sodian, MD, Cora Lueders, PhD, Liv Kraemer,"— Presentation transcript:

1 Tissue Engineering of Autologous Human Heart Valves Using Cryopreserved Vascular Umbilical Cord Cells  Ralf Sodian, MD, Cora Lueders, PhD, Liv Kraemer, MD, Wolfgang Kuebler, MD, Mehdi Shakibaei, MD, Bruno Reichart, MD, Sabine Daebritz, MD, Roland Hetzer, MD  The Annals of Thoracic Surgery  Volume 81, Issue 6, Pages (June 2006) DOI: /j.athoracsur Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Tissue engineering technique for fabrication of autologous human heart valves. Fetal echocardiography will be performed in order to diagnose abnormal cardiac anatomy (eg, pulmonary valve malformation). Vascular-wall cells of the umbilical cord will be isolated, expanded in vitro, and cryopreserved. At the ideal time point of surgery the cryopreserved human umbilical cord cells will be recultivated and seeded on a biodegradable heart valve scaffold. The cell polymer construct will be transferred into a dynamic cell culture system (“bioreactor”) and grown in vitro. After maturation in the bioreactor system the tissue-engineered heart valve will be implanted as an autologous heart valve into the same patient. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 (A) Three-dimensional reconstructed stereolithographic model from the inside of an aortic homograft. (B) Trileaflet heart valve scaffold from porous poly-4-hydroxybutyrate including sinus of Valsalva (seen from the aortic side) fabricated from the stereolithographic model. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 The fixed cryopreserved human umbilical cord cells showed myofibroblast-like morphology. Immunofluorescence staining revealed intracellular expression of anti-ASO2 (A), fibronectin (B), anti-alpha actin (C), and collagen (D). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Tissue-engineered heart valve after 7 days of static conditioning and an additional 7 days of dynamic conditioning in a bioreactor system. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 5 Hematoxylin and eosin staining of the tissue-engineered heart valves shows (A) layered tissue formation and cellular ingrowth in the dynamically conditioned constructs (black arrows). The white arrows show the degrading polymeric scaffold. (B) The controls showed hardly any cellular adherence and tissue formation with only a small number of cells attached to the scaffold and almost no cellular ingrowth (black arrows). The white arrow shows the degrading polymeric scaffold. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

7 Fig 6 Immunohistochemistry of the heart valves revealed positive expression for collagen (A, black arrows), fibronectin (B, black arrows), and actin (C, black arrows) in the dynamically conditioned heart valves. Static controls showed less organized extracellular matrix formation such as collagen (D, black arrows), fibronectin (E, black arrows), and actin (F, black arrows). The white arrows show the degrading polymeric scaffold. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

8 Fig 7 Electron microscopy of the dynamically conditioned heart valves (A) showed layered tissue formation and a confluent surface. In contrast, static controls showed only few cells and no cell ingrowth (B). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

9 Fig 8 Functional analysis showed an intact intracellular Ca2+ concentration after stimulation with histamine in the recultivated and cryopreserved cells (A and B) as well as in the dynamically conditioned constructs (C and D). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

10 Fig 9 Mechanical properties of the conditioned constructs showed an increase of the tensile strength in longitudinal direction in dynamically conditioned heart valves compared with static controls. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Tissue Engineering of Autologous Human Heart Valves Using Cryopreserved Vascular Umbilical Cord Cells  Ralf Sodian, MD, Cora Lueders, PhD, Liv Kraemer,"

Similar presentations

Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 

Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 
Use of Human Umbilical Cord Blood-Derived Progenitor Cells for Tissue-Engineered Heart Valves  Ralf Sodian, MD, Philipp Schaefermeier, PhD, Sybille Abegg-Zips,

Use of Human Umbilical Cord Blood-Derived Progenitor Cells for Tissue-Engineered Heart Valves  Ralf Sodian, MD, Philipp Schaefermeier, PhD, Sybille Abegg-Zips,
In Vitro Fabrication of a Tissue Engineered Human Cardiovascular Patch for Future Use in Cardiovascular Surgery  Chao Yang, MD, Ralf Sodian, MD, Ping.

In Vitro Fabrication of a Tissue Engineered Human Cardiovascular Patch for Future Use in Cardiovascular Surgery  Chao Yang, MD, Ralf Sodian, MD, Ping.
Bloodless Surgery of Acute Type A Aortic Dissection in a Jehovah’s Witness Patient  Miralem Pasic, MD, PhD, Wolfgang Ruisz, MD, Andreas Koster, MD, PhD,

Bloodless Surgery of Acute Type A Aortic Dissection in a Jehovah’s Witness Patient  Miralem Pasic, MD, PhD, Wolfgang Ruisz, MD, Andreas Koster, MD, PhD,
Novel Bioengineered Small Caliber Vascular Graft With Excellent One-Month Patency  Yosuke Ishii, MD, Russell T. Kronengold, PhD, Renu Virmani, MD, Elias.

Novel Bioengineered Small Caliber Vascular Graft With Excellent One-Month Patency  Yosuke Ishii, MD, Russell T. Kronengold, PhD, Renu Virmani, MD, Elias.
The influence of early-phase remodeling events on the biomechanical properties of engineered vascular tissues  Zehra Tosun, Carolina Villegas-Montoya,

The influence of early-phase remodeling events on the biomechanical properties of engineered vascular tissues  Zehra Tosun, Carolina Villegas-Montoya,
Fariba Chalajour, MD, Laura A

Fariba Chalajour, MD, Laura A
Primary Cardiac T-Cell Lymphoma Localized in the Mitral Valve

Primary Cardiac T-Cell Lymphoma Localized in the Mitral Valve
Biomatrix/Polymer Composite Material for Heart Valve Tissue Engineering  Christof Stamm, MD, Amir Khosravi, MD, Niels Grabow, MS, Kathleen Schmohl, PhD,

Biomatrix/Polymer Composite Material for Heart Valve Tissue Engineering  Christof Stamm, MD, Amir Khosravi, MD, Niels Grabow, MS, Kathleen Schmohl, PhD,
Dhruva K. Mishra, PhD, Steven D. Compean, BS, Michael J

Dhruva K. Mishra, PhD, Steven D. Compean, BS, Michael J
Novel Tissue-Engineered Biodegradable Material for Reconstruction of Vascular Wall  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Satoshi Taketani, MD, Kei Torikai,

Novel Tissue-Engineered Biodegradable Material for Reconstruction of Vascular Wall  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Satoshi Taketani, MD, Kei Torikai,
Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 

Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 
Mid-Term Clinical Results Using a Tissue-Engineered Pulmonary Valve to Reconstruct the Right Ventricular Outflow Tract During the Ross Procedure  Pascal.

Mid-Term Clinical Results Using a Tissue-Engineered Pulmonary Valve to Reconstruct the Right Ventricular Outflow Tract During the Ross Procedure  Pascal.
Dhruva K. Mishra, PhD, Michael J. Thrall, MD, Brandi N

Dhruva K. Mishra, PhD, Michael J. Thrall, MD, Brandi N
Engineered Living Blood Vessels: Functional Endothelia Generated From Human Umbilical Cord-Derived Progenitors  Dörthe Schmidt, MD, Lars M. Asmis, MD,

Engineered Living Blood Vessels: Functional Endothelia Generated From Human Umbilical Cord-Derived Progenitors  Dörthe Schmidt, MD, Lars M. Asmis, MD,
Ashwin K. Thiagarajasubramanian, MD, Sandip K. Zalawadiya, MD, Luis C

Ashwin K. Thiagarajasubramanian, MD, Sandip K. Zalawadiya, MD, Luis C
Mycotic Thoracic Aortic Aneurysm After Intravesical Bacillus Calmette–Guérin Treatment  Kenneth P. Seastedt, MD, Usman Ahmad, MD, Christopher Lau, MD,

Mycotic Thoracic Aortic Aneurysm After Intravesical Bacillus Calmette–Guérin Treatment  Kenneth P. Seastedt, MD, Usman Ahmad, MD, Christopher Lau, MD,
Constructive Remodeling of CorMatrix Extracellular Matrix After Aortic Root Repair in a 90-Year-Old Woman  Frank N. Slachman, MD  The Annals of Thoracic.

Constructive Remodeling of CorMatrix Extracellular Matrix After Aortic Root Repair in a 90-Year-Old Woman  Frank N. Slachman, MD  The Annals of Thoracic.
A Hybrid Tissue-Engineered Heart Valve

A Hybrid Tissue-Engineered Heart Valve
Surgical Removal and Replacement of Chronically Implanted Transcatheter Aortic Prostheses: How I Teach It  Abeel A. Mangi, MD, Mahesh Ramchandani, MD,

Surgical Removal and Replacement of Chronically Implanted Transcatheter Aortic Prostheses: How I Teach It  Abeel A. Mangi, MD, Mahesh Ramchandani, MD,

Similar presentations

Ads by Google